Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | CASP3 | P42574 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.37 |
| ▸ | RELA | Q04206 | 1/20 | 0.37 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.37 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.37 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL395410 | 0.83 | ALDH1A1 (0.39) | MAPTSMN1; SMN2NR1I2ALDH1A1HPGD | |
| SCHEMBL356134 | 0.83 | MAPT (0.44) | MAPTSMN1; SMN2ALDH1A1HPGDALOX15 | |
| SCHEMBL9308033 | 0.83 | MAPT (0.44) | MAPTSMN1; SMN2NR1I2ALDH1A1HPGD | |
| SCHEMBL15130526 | 0.79 | SRC (0.44) | MAPTSMN1; SMN2ALDH1A1HPGDNPSR1 | |
| SCHEMBL30972491 | 0.79 | ALDH1A1 (0.39) | ALDH1A1HPGDHSD17B10TDP1RAB9A | |
| SCHEMBL14020461 | 0.79 | ALDH1A1 (0.45) | MAPTSMN1; SMN2ALDH1A1HPGDALOX15 | |
| SCHEMBL6937282 | 0.79 | ALDH1A1 (0.35) | MAPTSMN1; SMN2NR1I2ALDH1A1HPGD | |
| SCHEMBL25532591 | 0.78 | ALDH1A1 (0.42) | MAPTSMN1; SMN2ALDH1A1NPC1RAB9A | |
| SCHEMBL3430867 | 0.78 | ALDH1A1 (0.50) | MAPTSMN1; SMN2NR1I2ALDH1A1HPGD | |
| SCHEMBL23802024 | 0.78 | PRKDC (0.41) | MAPTSMN1; SMN2ALDH1A1HPGDALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12234384-B2 | Adhesion-improving composition for textile material and associated reinforcing textile material | PORCHER INDUSTRIES (FR) | 2025-02-25 | — | — | US | claimed |
| CN-112135862-B | Composition for improving the adhesion of textile materials and related reinforced textile materials | 博舍工业公司 | 2022-06-03 | — | — | CN | claimed |
| US-20210115310-A1 | ADHESION-IMPROVING COMPOSITION FOR TEXTILE MATERIAL AND ASSOCIATED REINFORCING TEXTILE MATERIAL | PORCHER INDUSTRIES (FR) | 2021-04-22 | — | — | US | claimed |
| EP-3784719-A1 | ADHERENCE-IMPROVING COMPOSITION FOR TEXTILE MATERIAL AND ASSOCIATED REINFORCING TEXTILE MATERIAL | Porcher Industries (FR) | 2021-03-03 | — | — | EP | claimed |
| CN-112135862-A | Composition for improving the adhesion of textile materials and related reinforced textile materials | 博舍工业公司 | 2020-12-25 | — | — | CN | claimed |
| WO-2025053103-A1 | RESIN COMPOSITION EXCELLENT IN TRANSPARENCY AND MOLDED ARTICLE THEREOF | 株式会社ヘミセルロース | 2025-03-13 | — | — | WO | disclosed |
| US-12234384-B2 | Adhesion-improving composition for textile material and associated reinforcing textile material | PORCHER INDUSTRIES (FR) | 2025-02-25 | — | — | US | disclosed |
| US-11446389-B2 | Maytansinoid derivatives, conjugates thereof, and methods of use | REGENERON PHARMACEUTICALS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| CN-112135862-B | Composition for improving the adhesion of textile materials and related reinforced textile materials | 博舍工业公司 | 2022-06-03 | — | — | CN | disclosed |
| US-20210115310-A1 | ADHESION-IMPROVING COMPOSITION FOR TEXTILE MATERIAL AND ASSOCIATED REINFORCING TEXTILE MATERIAL | PORCHER INDUSTRIES (FR) | 2021-04-22 | — | — | US | disclosed |
| EP-3784719-A1 | ADHERENCE-IMPROVING COMPOSITION FOR TEXTILE MATERIAL AND ASSOCIATED REINFORCING TEXTILE MATERIAL | Porcher Industries (FR) | 2021-03-03 | — | — | EP | disclosed |
| CN-112135862-A | Composition for improving the adhesion of textile materials and related reinforced textile materials | 博舍工业公司 | 2020-12-25 | — | — | CN | disclosed |
| US-20200121806-A1 | MAYTANSINOID DERIVATIVES, CONJUGATES THEREOF, AND METHODS OF USE | REGENERON PHARMACEUTICALS, INC. | 2020-04-23 | — | — | US | disclosed |
| US-9950076-B2 | Maytansinoid derivatives, conjugates thereof, and methods of use | REGENERON PHARMACEUTICALS, INC. (US) | 2018-04-24 | — | — | US | disclosed |
| US-20170209591-A1 | MAYTANSINOID DERIVATIVES, CONJUGATES THEREOF, AND METHODS OF USE | REGENERON PHARMACEUTICALS, INC. | 2017-07-27 | — | — | US | disclosed |
| EP-2796455-A1 | METHOD FOR PRODUCING SULFONATE | Sumitomo Chemical Co., Ltd (JP) | 2014-10-29 | — | — | EP | disclosed |
| EP-1889826-B1 | METHOD FOR PRODUCING A HEXAHYDROFUROFURANOL DERIVATIVE | SUMITOMO CHEMICAL CO (JP) | 2011-10-26 | — | — | EP | disclosed |
| US-7951977-B2 | Process for producing hexahydrofurofuranol derivative | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-05-31 | — | — | US | disclosed |
| US-20090176999-A1 | Process for producing hexahydrofurofuranol derivative | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-07-09 | — | — | US | disclosed |
| EP-1889826-A1 | METHOD FOR PRODUCING HEXAHYDROFUROFURANOL DERIVATIVE | Sumitomo Chemical Company, Limited (JP) | 2008-02-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170209591-A1 | MAYTANSINOID DERIVATIVES, CONJUGATES THEREOF, AND METHODS OF USE | HNMT, SLC10A1, SLC10A2 | MAPT 3410/4885SMN1; SMN2 1273/4885NR1I2 1634/4885 |
| US-20090176999-A1 | Process for producing hexahydrofurofuranol derivative | DHFR, DHPS, CYP4B1 | MAPT 4176/4885SMN1; SMN2 2964/4885NR1I2 1065/4885 |
| US-20200121806-A1 | MAYTANSINOID DERIVATIVES, CONJUGATES THEREOF, AND METHODS OF USE | HNMT, SLC10A1, SLC10A2 | MAPT 3410/4885SMN1; SMN2 1273/4885NR1I2 1634/4885 |
| US-11446389-B2 | Maytansinoid derivatives, conjugates thereof, and methods of use | HNMT, SLC10A1, SLC10A2 | MAPT 3410/4885SMN1; SMN2 1273/4885NR1I2 1634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.